Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of an investigational hormone preparation vs dulaglutide in Japan
jRCT2080224591Phase 3Completed
- Start
- Mar 2019
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of dulaglutide (2 arms). Started Mar 2019; status: completed.
02
Drugs
dulaglutide
Beyond the preview
Go deeper on jRCT2080224591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224591.